Literature DB >> 1937808

Differential induction of tumor necrosis factor by bacteria expressing rough and smooth lipopolysaccharide phenotypes.

N M Kelly1, L Young, A S Cross.   

Abstract

The lipid A portion of the lipopolysaccharide (LPS) molecule of gram-negative bacteria has the ability to turn on the production of tumor necrosis factor (TNF) in macrophage cells. The question addressed in this paper was whether the presence of the polysaccharide moiety on the LPS molecule had any bearing on this ability. The question was asked (i) by using isolated LPS from a series of Salmonella mutants having progressively less polysaccharide attached to the lipid A portion of the molecule and (ii) by using whole bacteria expressing alternatively the smooth or rough LPS phenotype. Isolated LPS and bacteria were examined for their abilities to induce bioactive TNF in the mouse macrophage cell line RAW 264.7. The results indicated that the presence of long- or short-chain polysaccharide moieties had no bearing on the ability of the isolated LPS molecule to induce TNF. However, the presence of long-chain polysaccharides attached to the lipid moiety on the intact smooth bacterium was associated with a decreased ability to induce TNF. To test whether the bacteria were inducing TNF by a cell (bacterium)-to-cell (macrophage) contact mechanism or through a releasable product, the bacteria were removed from direct contact with the macrophage cells by using a Transwell filter insert. Under these conditions the rough bacteria continued to induce TNF, while the smooth bacteria were no longer capable of doing so. When filtrates from the bacteria were examined in the Limulus amebocyte lysate assay, the results showed that the rough bacteria were releasing approximately a log order more Limulus amebocyte lysate activity than the smooth bacteria. The results of this study suggest that rough bacteria may be superior inducers of TNF compared with their smooth counterparts because of a greater propensity to shed their LPS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937808      PMCID: PMC259068          DOI: 10.1128/iai.59.12.4491-4496.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Estimation of 3-deoxy sugars by means of the malonaldehyde-thiobarbituric acid reaction.

Authors:  M A CYNKIN; G ASHWELL
Journal:  Nature       Date:  1960-04-09       Impact factor: 49.962

2.  Activation of C3H/HeJ macrophage tumoricidal activity and cytokine release by R-chemotype lipopolysaccharide preparations. Differential effects of IFN-gamma.

Authors:  L M Flebbe; S K Chapes; D C Morrison
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

3.  Inhibition of activated nonresponder C3H/HeJ lymphocytes by lipopolysaccharide endotoxin.

Authors:  B M Sultzer; R Castagna
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

4.  Optimal induction of tumor necrosis factor production in human monocytes requires complete S-form lipopolysaccharide.

Authors:  D N Männel; W Falk
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

6.  Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies.

Authors:  G R Barclay; B B Scott
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

7.  Selective association of lipid-rich R-like lipopolysaccharide subunits with murine spleen cells.

Authors:  S A Goodman; D C Morrison
Journal:  Mol Immunol       Date:  1984-08       Impact factor: 4.407

8.  Induction of human granulocyte chemiluminescence by bacterial lipopolysaccharides.

Authors:  A Kapp; M Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

Review 9.  Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses.

Authors:  B Sherry; A Cerami
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

10.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.

Authors:  B Beutler; J Mahoney; N Le Trang; P Pekala; A Cerami
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more
  17 in total

1.  Cytokines in Salmonella infection.

Authors:  I Trebichavský
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

Review 2.  Choice of bacteria in animal models of sepsis.

Authors:  A S Cross; S M Opal; J C Sadoff; P Gemski
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

3.  Biological properties of structurally related alpha-helical cationic antimicrobial peptides.

Authors:  M G Scott; H Yan; R E Hancock
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

4.  Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria.

Authors:  M G Scott; M R Gold; R E Hancock
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Brucella abortus rough mutants are cytopathic for macrophages in culture.

Authors:  Jianwu Pei; Thomas A Ficht
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes.

Authors:  E Caron; T Peyrard; S Köhler; S Cabane; J P Liautard; J Dornand
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.

Authors:  J Weiss; P Elsbach; C Shu; J Castillo; L Grinna; A Horwitz; G Theofan
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-1A with lipopolysaccharides from rough and smooth gram-negative organisms.

Authors:  M A Mascelli; B Frederick; T Ely; D S Neblock; D J Shealy; K Y Pak; P E Daddona
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

9.  Activity of lipopolysaccharide-binding protein-bactericidal/permeability-increasing protein fusion peptide in an experimental model of Pseudomonas sepsis.

Authors:  S M Opal; J E Palardy; J W Jhung; C Donsky; R L Romulo; N Parejo; M N Marra
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

10.  Bioactive tumor necrosis factor in the sputa of cystic fibrosis patients.

Authors:  N Kelly; S Clee; B Nakielna
Journal:  Clin Diagn Lab Immunol       Date:  1995-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.